Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.